Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Parren

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Journal of Virology|November 17, 2001
Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodiesM B Zwick, M Wang, P Poignard, et al.
Nature Medicine|December 13, 1997
Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1M C Gauduin, P W Parren, R Weir, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1997
Production of a mouse/human chimeric IgE monoclonal antibody to the house dust mite allergen Der p 2 and its use for the absolute quantification of allergen-specific IgEJ Schuurman, G J Perdok, T E Lourens, et al.
Immunology Letters|June 1, 1997
Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine designP W Parren, M C Gauduin, R A Koup, et al.
AIDS Research and Human Retroviruses|July 1, 1996
Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen bindingJ M Binley, H J Ditzel, C F Barbas, et al.
Immunology Letters|July 1, 1997
Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design"P W Parren, M C Gauduin, R A Koup, et al.
Immunobiology|August 1, 1992
Polymorphism of the human Fc gamma receptor II (CD32): molecular basis and functional aspectsP A Warmerdam, P W Parren, A Vlug, et al.
The Journal of Experimental Medicine|October 23, 1997
Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralizationS Ugolini, I Mondor, P W Parren, et al.
Journal of Virology|July 11, 1998
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodiesN Sullivan, Y Sun, J Binley, et al.
Journal of Virology|April 29, 1998
Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificityP W Parren, I Mondor, D Naniche, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Journal of Virology|November 17, 2001
Neutralization synergy of human immunodeficiency virus type 1 primary isolates by cocktails of broadly neutralizing antibodiesM B Zwick, M Wang, P Poignard, et al.
Nature Medicine|December 13, 1997
Passive immunization with a human monoclonal antibody protects hu-PBL-SCID mice against challenge by primary isolates of HIV-1M C Gauduin, P W Parren, R Weir, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1997
Production of a mouse/human chimeric IgE monoclonal antibody to the house dust mite allergen Der p 2 and its use for the absolute quantification of allergen-specific IgEJ Schuurman, G J Perdok, T E Lourens, et al.
Immunology Letters|June 1, 1997
Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine designP W Parren, M C Gauduin, R A Koup, et al.
AIDS Research and Human Retroviruses|July 1, 1996
Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen bindingJ M Binley, H J Ditzel, C F Barbas, et al.
Immunology Letters|July 1, 1997
Erratum to "Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design"P W Parren, M C Gauduin, R A Koup, et al.
Immunobiology|August 1, 1992
Polymorphism of the human Fc gamma receptor II (CD32): molecular basis and functional aspectsP A Warmerdam, P W Parren, A Vlug, et al.
The Journal of Experimental Medicine|October 23, 1997
Inhibition of virus attachment to CD4+ target cells is a major mechanism of T cell line-adapted HIV-1 neutralizationS Ugolini, I Mondor, P W Parren, et al.
Journal of Virology|July 11, 1998
Determinants of human immunodeficiency virus type 1 envelope glycoprotein activation by soluble CD4 and monoclonal antibodiesN Sullivan, Y Sun, J Binley, et al.
Journal of Virology|April 29, 1998
Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificityP W Parren, I Mondor, D Naniche, et al.
Pageof 6